Rockwell Medical (RMTI) Asset Writedowns and Impairment (2018 - 2026)

Rockwell Medical (RMTI) has reported Asset Writedowns and Impairment for 9 consecutive years, with -$450000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Asset Writedowns and Impairment changed N/A year-over-year to -$450000.0; the trailing twelve-month figure through Jun 2026 stood at -$1.1 million (down 274.63% YoY), and the FY2025 full-year result was -$425000.0, down 200.0% from the prior year.
• Asset Writedowns and Impairment grew to -$450000.0 in Q2 2026 per RMTI's latest filing, from -$603000.0 in the prior quarter.
• Across five years, Asset Writedowns and Impairment topped out at $1.1 million in Q3 2023 and bottomed at -$603000.0 in Q4 2025.
• Historically, Asset Writedowns and Impairment has averaged $157250.0 across 5 years, with a median of $237500.0 in 2022.
• The sharpest annual moves came in 2022 and 2025: Asset Writedowns and Impairment jumped 431.58% in 2022, then plunged 241.88% in 2025.
• Over 5 years, Asset Writedowns and Impairment stood at $303000.0 in 2022, then jumped by 262.38% to $1.1 million in 2023, then tumbled by 61.29% to $425000.0 in 2024, then slumped by 241.88% to -$603000.0 in 2025, then rose by 25.37% to -$450000.0 in 2026.
• According to Business Quant data, Asset Writedowns and Impairment over the past three periods registered -$450000.0, -$603000.0, and $178000.0 for Q2 2026, Q4 2025, and Q1 2025 respectively.